Abdel-Dayem Khairy, Eweda Inas I, El-Sherbiny Ashraf, Dimitry Marc O, Nammas Wail
Cardiology Department, Faculty of Medicine, Ain Shams University.
Internal Medicine Department, National Research Center, Cairo, Egypt.
Acta Cardiol Sin. 2016 Nov;32(6):649-655. doi: 10.6515/acs20151112b.
We explored the value of admission levels of N-terminal pro-brain natriuretic peptide (NTProBNP) that best predicts poor myocardial tissue perfusion following primary percutaneous coronary intervention (PPCI) in patients admitted with acute ST-segment-elevation myocardial infarction (STEMI).
We enrolled 90 consecutive patients admitted with acute STEMI who underwent PPCI and achieved post-procedural TIMI flow grade 3 in the infarct-related artery. We measured levels of NTProBNP from admission blood samples. Thereafter, we assessed post-procedural myocardial blush grade (MBG) at the end of PPCI, and further measured ST segment resolution (STR) 90 minutes following PPCI. The primary endpoint was STR < 50%; furthermore, the co-primary angiographic endpoint was postprocedural MBG 0/1.
The mean age of study subjects was 53.6 ± 10.9 years (74.4% males). We found that NTProBNP was higher in patients with STR < 50% versus those with STR ≥ 50% (p < 0.001), and in patients with post-procedural MBG 0/1 versus those with MBG 2/3 (p < 0.001). A value of NTProBNP ≥ 420 ng/L was the optimal cutoff value that best predicted < 50% STR; it predicted < 50% STR with sensitivity, specificity, positive and negative predictive value of 98.4%, 92.3%, 96.9%, and 96%, respectively. Likewise, a value of NTProBNP ≥ 570 ng/L was the optimal cutoff value that best predicted postprocedural MBG 0/1; it predicted MBG 0/1 with sensitivity, specificity, positive and negative predictive value of 92.2%, 66.7%, 78.3%, and 86.7%, respectively.
In patients with STEMI who underwent PPCI and ended up with successful recanalization of the epicardial infarct-related artery, elevated admission levels of NTProBNP predicted incomplete post-procedural STR with good sensitivity and specificity, and predicted poor post-procedural myocardial blush with good sensitivity and moderate specificity.
我们探讨了N末端脑钠肽前体(NTProBNP)入院时的水平对于急性ST段抬高型心肌梗死(STEMI)患者接受直接经皮冠状动脉介入治疗(PPCI)后心肌组织灌注不良的最佳预测价值。
我们连续纳入90例接受PPCI且梗死相关动脉术后达到TIMI血流3级的急性STEMI患者。我们检测了入院血样中的NTProBNP水平。此后,我们在PPCI结束时评估了术后心肌灌注分级(MBG),并在PPCI后90分钟进一步测量了ST段回落(STR)。主要终点是STR<50%;此外,共同主要血管造影终点是术后MBG为0/1。
研究对象的平均年龄为53.6±10.9岁(男性占74.4%)。我们发现,STR<50%的患者NTProBNP水平高于STR≥50%的患者(p<0.001),术后MBG为0/1的患者NTProBNP水平高于MBG为2/3的患者(p<0.001)。NTProBNP≥420 ng/L是最佳截断值,能最好地预测STR<50%;它预测STR<50%的敏感性、特异性、阳性预测值和阴性预测值分别为98.4%、92.3%、96.9%和96%。同样,NTProBNP≥570 ng/L是最佳截断值,能最好地预测术后MBG为0/1;它预测MBG为0/1的敏感性、特异性、阳性预测值和阴性预测值分别为92.2%、66.7%、78.3%和86.7%。
在接受PPCI且心外膜梗死相关动脉成功再通的STEMI患者中,入院时NTProBNP水平升高对术后STR不完全具有良好的敏感性和特异性,对术后心肌灌注不良具有良好的敏感性和中等特异性。